Dianthus Therapeutics, Inc.
76.78USD
-1.7500 (-2.23%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DNTH.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.95▲ | -$1.02 | 2 | 1 |
| Next quarter | -$1.11▲ | -$1.18 | 2 | 1 |
| Current year | -$3.81▲ | -$3.93 | 2 | 1 |
| Next year | -$4.61▲ | -$4.65 | 2 | 1 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.91 | -$0.9 | +0.01 (+1.0%) |
| 2026-03-31 | -$1.1 | -$0.85 | +0.25 (+22.9%) |
| 2025-12-31 | -$1.03 | -$1.43 | -0.40 (-38.6%) |
| 2025-09-30 | -$0.9 | -$0.97 | -0.07 (-7.9%) |
61 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterated | Buy | $158 | Oct 15, 2026 |
| JP Morgan | Initiated | Overweight | $135 | Sep 11, 2026 |
| Citigroup | Initiated | Buy | $156 | Sep 4, 2026 |
| Truist Securities | Maintained | Buy | $110 $128 | Aug 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $130 $158 | Aug 6, 2026 |
| Wedbush | Maintained | Outperform | $105 $122 | Aug 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $120 $134 | Aug 3, 2026 |
| Wedbush | Maintained | Outperform | $103 $105 | May 6, 2026 |
| Wolfe Research | Initiated | Outperform | $98 | Apr 9, 2026 |
| Wells Fargo | Initiated | Overweight | $135 | Mar 19, 2026 |
| Wedbush | Maintained | Outperform | $80 $103 | Mar 12, 2026 |
| Wedbush | Maintained | Outperform | $55 $80 | Mar 10, 2026 |
| Raymond James | Upgraded from Outperform | Strong Buy | $63 $123 | Mar 10, 2026 |
| Baird | Maintained | Outperform | $67 $132 | Mar 10, 2026 |
| Clear Street | Maintained | Buy | $100 $130 | Mar 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $47 $130 | Mar 9, 2026 |
| Oppenheimer | Maintained | Outperform | $125 $145 | Mar 9, 2026 |
| Truist Securities | Maintained | Buy | $63 $110 | Mar 9, 2026 |
| Guggenheim | Maintained | Buy | $100 $200 | Mar 4, 2026 |
| Wedbush | Maintained | Outperform | $46 $55 | Feb 11, 2026 |
| Jefferies | Maintained | Buy | $66 $81 | Feb 2, 2026 |
| Truist Securities | Maintained | Buy | $56 $63 | Jan 8, 2026 |
| Wedbush | Reiterated | Outperform | $46 | Dec 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $40 $47 | Nov 10, 2025 |
| Wedbush | Maintained | Outperform | $44 $46 | Nov 6, 2025 |
56 filings from 9 insiders · 11 buy / 10 sell over 6m
Officers and directors of DNTH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | ExerciseStock Option (Right to Buy) | 20.0k | — | — | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Sell | 700 | $104.39 | $73k | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Sell | 1.1k | $103.20 | $114k | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Sell | 3.5k | $102.39 | $358k | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Sell | 6.8k | $101.37 | $686k | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Sell | 7.9k | $100.43 | $796k | Sep 17, 2026 |
| CARR EDWARDOfficer, CHIEF ACCOUNTING OFFICER | Exercise | 20.0k | $17.88 | $358k | Sep 17, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | ExerciseStock Option (Right to Buy) | 9.4k | — | — | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | ExerciseStock Option (Right to Buy) | 6.2k | — | — | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | ExerciseStock Option (Right to Buy) | 7.5k | — | — | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Sell | 13.3k | $106.74 | $1.42M | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Sell | 7.2k | $106.25 | $767k | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Sell | 2.6k | $105.19 | $273k | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Exercise | 9.4k | $22.07 | $207k | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Exercise | 6.2k | $21.77 | $136k | Sep 1, 2026 |
| Randhawa SimratOfficer, EVP, Head of R&D | Exercise | 7.5k | $17.88 | $134k | Sep 1, 2026 |
| READ SIMON J.Director | Exercise | 2.8k | $18.36 | $51k | Aug 19, 2026 |
| READ SIMON J.Director | Sell | 2.8k | $117.55 | $327k | Aug 19, 2026 |
| VENESS ADAM MGeneral Counsel | Exercise | 15.0k | $18.17 | $273k | Aug 13, 2026 |
| READ SIMON J.Director | Exercise | 2.8k | $18.36 | $51k | Aug 10, 2026 |
No analyst notes on DNTH yet.
Members whose judged calls on DNTH have played out most reliably.
No settled calls on DNTH yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 16 | 0 | 0 | 0 | Buy1.94 |
| 1 mo ago | 1 | 16 | 0 | 0 | 0 | Buy1.94 |
| 2 mo ago | 0 | 15 | 0 | 0 | 0 | Buy2.00 |
| 3 mo ago | 0 | 15 | 0 | 0 | 0 | Buy2.00 |